File(s) not publicly available
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia
journal contributionposted on 2023-06-08, 12:41 authored by Paola Lanuti, Fausta Ciccocioppo, Laura Bonanni, Marco Marchisio, Raskit Lachmann, Naji TabetNaji Tabet, Laura Pierdomenico, Eugenio Santavenere, Virginia Catinella, Antonio Iacone, Astrid Thomas, Domenico Gambi, Sebastiano Miscia, Marco Onofrj, Florian KernFlorian Kern
Alzheimer's disease and dementia with Lewy bodies are the most common neurodegenerative dementias in old age. Accurate diagnosis of these conditions has important clinical implications because they tend to be confounded. In the brain of Alzheimer's disease patients amyloid-beta is produced in excess and deposited as plaques, forming the hallmark of this condition. Lymphocytes have been implicated in the process of amyloid-beta removal and inflammation occurrence. Here we investigated peripheral amyloid-beta1-42-specific T-cells by multicolor flow cytometry to simultaneously detect and characterize activation markers and cell signaling proteins (phospho-protein kinase C) in patients with Alzheimer's disease or Lewy body dementia and in healthy controls. Results indicate that only Alzheimer's disease patients display small subsets of peripheral amyloid-beta1-42-specific T-cells, characterized by bright expression of phosphorylated-protein kinase C-delta or -zeta whose significance although discussed, is far from being understood. The identification of such subsets, anyhow, may strongly contribute to distinguish Alzheimer's disease from dementia with Lewy bodies, opening possible new routes to early therapeutic strategies.
JournalNeurobiology of Aging
Department affiliated with
- Clinical and Experimental Medicine Publications
Full text available